Newly Developed Psoriasis in a Patient with Telangiectasia Macularis Eruptiva Perstans and Systemic Mastocytosis Treated with Interferon

The authors present a rare case of a patient with telangiectasia macular eruptiva perstans, with confirmed D816V mutation which later progressed to systemic mastocytosis confirmed by trepanobiopsy. First-line treatment – phototherapy – had to be stopped, and systemic treatment with interferon alpha-...

Full description

Saved in:
Bibliographic Details
Published in:Case reports in dermatology 2021-12, Vol.13 (3), p.558-562
Main Authors: Péčová, Tatiana, Burjanivová, Tatiana, Malicherová, Bibiana, Péč, Martin Jozef, Rohoň, Igor, Madleňák, Matúš, Adamicová, Katarína, Péč, Juraj
Format: Article
Language:English
Subjects:
Biopsy
Blood vessels
Bone marrow
Case reports
Cell growth
Disease
Interferon
Lymphocytes
mastocytosis
Mutation
Psoriasis
Single Case
Skin
telangiectasia macularis eruptiva perstans
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The authors present a rare case of a patient with telangiectasia macular eruptiva perstans, with confirmed D816V mutation which later progressed to systemic mastocytosis confirmed by trepanobiopsy. First-line treatment – phototherapy – had to be stopped, and systemic treatment with interferon alpha-2a was initiated. The treatment was successful with regression of skin lesions as well as mast cell infiltrates in the bone marrow. However, the treatment was complicated by the onset of psoriasis lesions.
ISSN:1662-6567
1662-6567
DOI:10.1159/000520533